- Latest available (Revised)
- Point in Time (12/06/2019)
- Original (As adopted by EU)
Commission Delegated Regulation (EU) 2016/127 of 25 September 2015 supplementing Regulation (EU) No 609/2013 of the European Parliament and of the Council as regards the specific compositional and information requirements for infant formula and follow-on formula and as regards requirements on information relating to infant and young child feeding (Text with EEA relevance)
When the UK left the EU, legislation.gov.uk published EU legislation that had been published by the EU up to IP completion day (31 December 2020 11.00 p.m.). On legislation.gov.uk, these items of legislation are kept up-to-date with any amendments made by the UK since then.
Legislation.gov.uk publishes the UK version. EUR-Lex publishes the EU version. The EU Exit Web Archive holds a snapshot of EUR-Lex’s version from IP completion day (31 December 2020 11.00 p.m.).
Point in time view as at 12/06/2019.
There are currently no known outstanding effects for the Commission Delegated Regulation (EU) 2016/127, ANNEX I.
Revised legislation carried on this site may not be fully up to date. At the current time any known changes or effects made by subsequent legislation have been applied to the text of the legislation you are viewing by the editorial team. Please see ‘Frequently Asked Questions’ for details regarding the timescales for which new effects are identified and recorded on this site.
Minimum | Maximum |
---|---|
250 kJ/100 ml | 293 kJ/100 ml |
(60 kcal/100 ml) | (70 kcal/100 ml) |
(Protein content = nitrogen content × 6,25)
Minimum | Maximum |
---|---|
0,43 g/100 kJ | 0,6 g/100 kJ |
(1,8 g/100 kcal) | (2,5 g/100 kcal) |
For an equal energy value, infant formula manufactured from cows' milk or goats' milk proteins must contain an available quantity of each indispensable and conditionally indispensable amino acid at least equal to that contained in the reference protein as set out in Section A of Annex III. Nevertheless, for calculation purposes, the concentration of methionine and cysteine may be added together if the methionine:cysteine ratio is not greater than 2, and the concentration of phenylalanine and tyrosine may be added together if the tyrosine:phenylalanine ratio is not greater than 2. The ratio of methionine:cysteine and of tyrosine:phenylalanine may be greater than 2, provided that the suitability of the product concerned for infants is demonstrated in accordance with Article 3(3).
The L-carnitine content shall be at least equal to 0,3 mg/100 kJ (1,2 mg/100 kcal).
Minimum | Maximum |
---|---|
0,54 g/100 kJ | 0,67 g/100 kJ |
(2,25 g/100 kcal) | (2,8 g/100 kcal) |
Only protein isolates from soya shall be used in manufacturing this infant formula.
For an equal energy value, infant formula manufactured from soya protein isolates, alone or in a mixture with cows' milk or goats' milk proteins, must contain an available quantity of each indispensable and conditionally indispensable amino acid at least equal to that contained in the reference protein as set out in Section A of Annex III. Nevertheless, for calculation purposes, the concentration of methionine and cysteine may be added together if the methionine:cysteine ratio is not greater than 2, and the concentration of phenylalanine and tyrosine may be added together if the tyrosine:phenylalanine ratio is not greater than 2. The ratio of methionine:cysteine and of tyrosine:phenylalanine may be greater than 2, provided that the suitability of the product concerned for infants is demonstrated in accordance with Article 3(3).
The L-carnitine content shall be at least equal to 0,3 mg/100 kJ (1,2 mg/100 kcal).
Minimum | Maximum |
---|---|
0,44 g/100 kJ | 0,67 g/100 kJ |
(1,86 g/100 kcal) | (2,8 g/100 kcal) |
Demineralised sweet whey protein derived from cows' milk after enzymatic precipitation of caseins using chymosin, consisting of:
63 % caseino-glycomacropeptide free whey protein isolate with a minimum protein content of 95 % of dry matter and protein denaturation of less than 70 % and a maximum ash content of 3 %; and
37 % sweet whey protein concentrate with a minimum protein content of 87 % of dry matter and protein denaturation of less than 70 % and a maximum ash content of 3,5 %.
Two-stage hydrolysis process using a trypsin preparation with a heat-treatment step (from 3 to 10 minutes at 80 to 100 °C) between the two hydrolysis steps.
For an equal energy value, infant formula manufactured from protein hydrolysates must contain an available quantity of each indispensable and conditionally indispensable amino acid at least equal to that contained in the reference protein as set out in Section B of Annex III. Nevertheless, for calculation purposes, the concentration of methionine and cysteine may be added together if the methionine:cysteine ratio is not greater than 2, and the concentration of phenylalanine and tyrosine may be added together if the tyrosine:phenylalanine ratio is not greater than 2. The ratio of methionine:cysteine and of tyrosine:phenylalanine may be greater than 2, provided that the suitability of the product concerned for infants is demonstrated in accordance with Article 3(3).
The L-carnitine content shall be at least equal to 0,3 mg/100 kJ (1,2 mg/100 kcal).
If added to infant formula, the amount of taurine shall not be greater than 2,9 mg/100 kJ (12 mg/100 kcal).
Minimum | Maximum |
---|---|
6,0 mg/100 kJ | 12 mg/100 kJ |
(25 mg/100 kcal) | (50 mg/100 kcal) |
Minimum | Maximum |
---|---|
1,1 g/100 kJ | 1,4 g/100 kJ |
(4,4 g/100 kcal) | (6,0 g/100 kcal) |
sesame seed oil,
cotton seed oil.
Textual Amendments
Minimum | Maximum |
---|---|
120 mg/100 kJ | 300 mg/100 kJ |
(500 mg/100 kcal) | (1 200 mg/100 kcal) |
Minimum | Maximum |
---|---|
12 mg/100 kJ | 24 mg/100 kJ |
(50 mg/100 kcal) | (100 mg/100 kcal) |
Minimum | Maximum |
---|---|
4,8 mg/100 kJ | 12 mg/100 kJ |
(20 mg/100 kcal) | (50 mg/100 kcal) |
The eicosapentaenoic acid (20:5 n-3) content shall not exceed that of docosahexaenoic (22:6 n-3) acid content.
The amount of phospholipids in infant formula shall not be greater than 2 g/l.
Minimum | Maximum |
---|---|
0,96 mg/100 kJ | 9,6 mg/100 kJ |
(4 mg/100 kcal) | (40 mg/100 kcal) |
Minimum | Maximum |
---|---|
2,2 g/100 kJ | 3,3 g/100 kJ |
(9 g/100 kcal) | (14 g/100 kcal) |
lactose,
maltose,
sucrose,
glucose,
glucose syrup or dried glucose syrup,
malto-dextrins,
pre-cooked starch (naturally free of gluten),
gelatinised starch (naturally free of gluten).
Minimum | Maximum |
---|---|
1,1 g/100 kJ | — |
(4,5 g/100 kcal) | — |
Those minimum levels shall not apply to infant formula:
in which soya protein isolates represent more than 50 % of the total protein content, or
bearing the statement ‘lactose free’ in accordance with Article 9(2).
Sucrose may only be added to infant formula manufactured from protein hydrolysates. If added, the sucrose content shall not exceed 20 % of the total carbohydrate content.
Glucose may only be added to infant formula manufactured from protein hydrolysates. If added, the glucose content shall not exceed 0,5 g/100 kJ (2 g/100 kcal).
Glucose syrup or dried glucose syrup may be added to infant formula manufactured from cows' milk or goats' milk proteins or infant formula manufactured from soya protein isolates (alone or in a mixture with cows' milk or goats' milk proteins) only if its dextrose equivalent does not exceed 32. If glucose syrup or dried glucose syrup is added to these products, the glucose content resulting from glucose syrup or dried glucose syrup shall not exceed 0,2 g/100 kJ (0,84 g/100 kcal).
The maximum glucose amounts laid down in point 8.4 shall apply if glucose syrup or dried glucose syrup is added to infant formula manufactured from protein hydrolysates.
Minimum | Maximum |
---|---|
— | 2 g/100 ml, and 30 % of the total carbohydrate content |
Fructo-oligosaccharides and galacto-oligosaccharides may be added to infant formula. In that case their content shall not exceed: 0,8 g/100 ml in a combination of 90 % oligogalactosyl-lactose and 10 % high molecular weight oligofructosyl-saccharose.
Other combinations and maximum levels of fructo-oligosaccharides and galacto-oligosaccharides may be used, provided that their suitability for infants is demonstrated in accordance with Article 3(3).
a Total phosphorus. | ||||
Per 100 kJ | Per 100 kcal | |||
---|---|---|---|---|
Minimum | Maximum | Minimum | Maximum | |
Sodium (mg) | 6 | 14,3 | 25 | 60 |
Potassium (mg) | 19,1 | 38,2 | 80 | 160 |
Chloride (mg) | 14,3 | 38,2 | 60 | 160 |
Calcium (mg) | 12 | 33,5 | 50 | 140 |
Phosphorus (mg)a | 6 | 21,5 | 25 | 90 |
Magnesium (mg) | 1,2 | 3,6 | 5 | 15 |
Iron (mg) | 0,07 | 0,31 | 0,3 | 1,3 |
Zinc (mg) | 0,12 | 0,24 | 0,5 | 1 |
Copper (μg) | 14,3 | 24 | 60 | 100 |
Iodine (μg) | 3,6 | 6,9 | 15 | 29 |
Selenium (μg) | 0,72 | 2 | 3 | 8,6 |
Manganese (μg) | 0,24 | 24 | 1 | 100 |
Molybdenum (μg) | — | 3,3 | — | 14 |
Fluoride (μg) | — | 24 | — | 100 |
The calcium:available phosphorus molar ratio shall not be less than 1 nor greater than 2. The amount of available phosphorus shall be calculated as 80 % of total phosphorus for infant formula manufactured from cow's milk protein, goats' milk protein or protein hydrolysates.
All requirements of point 10.1 shall apply, except for those concerning iron, phosphorus and zinc, which shall be as follows:
a Total phosphorus. | ||||
Per 100 kJ | Per 100 kcal | |||
---|---|---|---|---|
Minimum | Maximum | Minimum | Maximum | |
Iron (mg) | 0,11 | 0,48 | 0,45 | 2 |
Phosphorus (mg)a | 7,2 | 24 | 30 | 100 |
Zinc (mg) | 0,18 | 0,3 | 0,75 | 1,25 |
The calcium:available phosphorus molar ratio shall not be less than 1 nor greater than 2. The amount of available phosphorus shall be calculated as 70 % of total phosphorus for infant formula manufactured from soya protein isolates.
a Preformed vitamin A; RE = all trans retinol equivalent. | ||||
b Preformed niacin. | ||||
c Dietary folate equivalent: 1 μg DFE = 1 μg food folate = 0,6 μg folic acid from formula. | ||||
d Based on vitamin E activity of RRR-α-tocopherol. | ||||
Per 100 kJ | Per 100 kcal | |||
---|---|---|---|---|
Minimum | Maximum | Minimum | Maximum | |
Vitamin A (μg-RE)a | 16,7 | 27,2 | 70 | 114 |
[F1Vitamin D (μg) | 0,48 | 0,6 | 2 | 2,5] |
Thiamine (μg) | 9,6 | 72 | 40 | 300 |
Riboflavin (μg) | 14,3 | 95,6 | 60 | 400 |
Niacin (mg)b | 0,1 | 0,36 | 0,4 | 1,5 |
Pantothenic acid (mg) | 0,1 | 0,48 | 0,4 | 2 |
Vitamin B6 (μg) | 4,8 | 41,8 | 20 | 175 |
Biotin (μg) | 0,24 | 1,8 | 1 | 7,5 |
Folate (μg-DFE)c | 3,6 | 11,4 | 15 | 47,6 |
Vitamin B12 (μg) | 0,02 | 0,12 | 0,1 | 0,5 |
Vitamin C (mg) | 0,96 | 7,2 | 4 | 30 |
Vitamin K (μg) | 0,24 | 6 | 1 | 25 |
Vitamin E (mg α-tocopherol)d | 0,14 | 1,2 | 0,6 | 5 |
The following nucleotides may be added:
a The total concentration of nucleotides shall not exceed 1,2 mg/100 kJ (5 mg/100 kcal). | ||
Maximuma | ||
---|---|---|
(mg/100 kJ) | (mg/100 kcal) | |
cytidine 5′-monophosphate | 0,60 | 2,50 |
uridine 5′-monophosphate | 0,42 | 1,75 |
adenosine 5′-monophosphate | 0,36 | 1,50 |
guanosine 5′-monophosphate | 0,12 | 0,50 |
inosine 5′-monophosphate | 0,24 | 1,00 |
Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.
Original (As adopted by EU): The original version of the legislation as it stood when it was first adopted in the EU. No changes have been applied to the text.
Point in Time: This becomes available after navigating to view revised legislation as it stood at a certain point in time via Advanced Features > Show Timeline of Changes or via a point in time advanced search.
Geographical Extent: Indicates the geographical area that this provision applies to. For further information see ‘Frequently Asked Questions’.
Show Timeline of Changes: See how this legislation has or could change over time. Turning this feature on will show extra navigation options to go to these specific points in time. Return to the latest available version by using the controls above in the What Version box.
Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:
This timeline shows the different versions taken from EUR-Lex before exit day and during the implementation period as well as any subsequent versions created after the implementation period as a result of changes made by UK legislation.
The dates for the EU versions are taken from the document dates on EUR-Lex and may not always coincide with when the changes came into force for the document.
For any versions created after the implementation period as a result of changes made by UK legislation the date will coincide with the earliest date on which the change (e.g an insertion, a repeal or a substitution) that was applied came into force. For further information see our guide to revised legislation on Understanding Legislation.
Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:
Click 'View More' or select 'More Resources' tab for additional information including: